Rutgers Cancer Institute of NJ Discovers New Role for Enzyme; Could Have Implications for Cancer, Neurologic Disease
New Brunswick, NJ, April 2, 2014 — Research from Rutgers Cancer Institute of New Jersey shows that a new function discovered for a long-studied enzyme could have implications for the diagnosis and treatment of some cancers and neurological disease.
The work involves superoxide dismutase 1 (Sod1), an enzyme that for nearly half a century has been known to remove a specific radical byproduct created during the energy-producing process of cell metabolism. Read the rest of this entry »
April 2, 2014 – It pays to go to college in New Jersey — literally. Payscale, the creators of the largest salary database in the world, have analyzed how much undergrads pay to attend more than 1,300 different institutions, and what they can expect to make in the 20 years after graduation.
All that data revealed eight Garden State institutions fall in the top 250 when it comes to return on investment.
The list looks at 20-year return on investment, compared to total cost, which includes room and board, books and supplies, in addition to tuition. Read the rest of this entry »
New Brunswick, NJ, March 31, 2014 — The HealthCare Institute of New Jersey (HINJ) and NEHI (The Network for Excellence in Health Innovation) will host “Innovation in an Era of Payment Reform: How Will New Jersey’s Life Sciences Companies Respond?” on Tuesday, April 1 from 8:30 to 11:30 a.m. at the Crowne Plaza Monroe South Brunswick in Monroe Township, NJ.
Health care payment reform is already transforming the way health care providers deliver care throughout the United States. Payment reform will not only influence the quality and cost of health care, it will also impact innovation in New Jersey’s historically dynamic life sciences sector. Read the rest of this entry »
New Brunswick, NJ, March 27, 2014 —According to the Centers for Disease Control and Prevention, nearly 84,000 women each year are diagnosed with a gynecologic cancer, and 29,000 die from one of these diseases.
Physician scientists at Rutgers Cancer Institute of New Jersey continue to make great strides in this area, advancing scientific and clinical knowledge to combat cervical, ovarian, uterine, vaginal and other cancers of the reproductive system.
Lorna Rodriguez, MD, PhD, a gynecologic oncologist and director of the Cancer Institute of New Jersey’s precision medicine initiative, gave an oral presentation at the Society of Gynecologic Oncology’s (SGO) 45th Annual Meeting on Women’s Cancer this past week that focuses on recurrent or advanced stage cervical cancer. Read the rest of this entry »